Lexaria Bioscience reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Lexaria Bioscience using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
LEXX | Lexaria Bioscience | -$0.37 | -$0.10 | -$0.13 | -30.00% | $77.71K | $150.00K | $84.00K | -44.00% | 07/12/2024 | Get Alert |
LEXX | Lexaria Bioscience | -$0.22 | -$0.10 | -$0.06 | 40.00% | $35.02K | — | $145.00K | — | 04/09/2024 | Get Alert |
LEXX | Lexaria Bioscience | -$0.30 | — | -$0.13 | — | $101.48K | — | $151.28K | — | 01/12/2024 | Get Alert |
LEXX | Lexaria Bioscience | -$0.24 | -$0.13 | -$0.12 | 7.69% | $111.15K | $170.00K | $0.00 | -100.00% | 11/20/2023 | Get Alert |
LEXX | Lexaria Bioscience | -$0.41 | — | -$0.37 | — | $99.72K | — | $93.15K | — | 07/14/2023 | Get Alert |
LEXX | Lexaria Bioscience | -$0.25 | — | -$0.22 | — | $30.65K | — | $35.02K | — | 04/14/2023 | Get Alert |
LEXX | Lexaria Bioscience | -$0.35 | — | -$0.30 | — | $13.88K | — | $101.48K | — | 01/17/2023 | Get Alert |
LEXX | Lexaria Bioscience | -$0.25 | -$0.21 | -$0.24 | -14.29% | $31.02K | — | $111.15K | — | 11/28/2022 | Get Alert |
LEXX | Lexaria Bioscience | -$0.40 | -$0.21 | -$0.41 | -95.24% | $204.06K | — | $99.72K | — | 07/14/2022 | Get Alert |
LEXX | Lexaria Bioscience | -$0.27 | — | -$0.25 | — | $192.01K | — | $30.65K | — | 04/11/2022 | Get Alert |
LEXX | Lexaria Bioscience | -$0.24 | — | -$0.35 | — | $295.66K | — | $13.88K | — | 01/14/2022 | Get Alert |
LEXX | Lexaria Bioscience | — | — | -$0.25 | — | — | — | $31.02K | — | 11/29/2021 | Get Alert |
LEXX | Lexaria Bioscience | — | — | -$0.40 | — | — | — | $204.06K | — | 07/15/2021 | Get Alert |
LEXX | Lexaria Bioscience | — | — | -$0.27 | — | — | — | $192.01K | — | 04/14/2021 | Get Alert |
LEXX | Lexaria Bioscience | — | — | -$0.24 | — | — | — | $295.66K | — | 01/14/2021 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-12 | $-0.13 | $-0.10 | -30.0 % |
Mar 2024 | 2024-04-09 | $-0.06 | $-0.10 | 40.0 % |
Sep 2023 | 2023-11-20 | $-0.12 | $-0.13 | 7.69 % |
Sep 2022 | 2022-11-28 | $-0.24 | $-0.21 | -14.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-12 | $84.00K | $150.00K | -44.0 % |
Sep 2023 | 2023-11-20 | $0 | $170.00K | -100.0 % |
Lexaria Bioscience ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on July 12, 2024 for Q3.
Lexaria Bioscience ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on July 12, 2024 for Q3 and the Actual EPS was $-0.13, which missed the estimate of $-0.10.
Lexaria Bioscience ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on July 12, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which missed the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.